How do we process the gravity of what we do?
In his regular column in Oncology Times, Cleveland Clinic Cancer Center Chair Brian Bolwell, MD, FACP, explores topics critical to leading cancer centers in today’s healthcare environment. This time, he gets personal:
Advertisement
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy
“I think those of us who chose oncology did so with open eyes. We knew that a lot of our patients would die of cancer. And we are ok with that. We can help them throughout their journey. We see many people who are at their best when things are at their worst. We are also in a field that is highly intellectual with a rapidly expanding knowledge base—no other field of medicine is exploding with new discoveries and new treatments to the extent cancer medicine is. The ability to offer new therapies based on immunology or genomics is energizing. But year after year of getting calls in the middle of the day that one of our patients has died—with other patients waiting, or other issues that need to be addressed, and no time to adequately process the news—takes its toll. And I wonder if that toll is cumulative.”
Read the full column here.
Photo Credit: ©Russell Lee
Advertisement
Advertisement
Timing and type of side effects differ greatly from chemotherapy
Dedicated multidisciplinary teams support 84 ultra-rare cancers
Sessions explore treatment advances and multidisciplinary care
New research from Cleveland Clinic helps explain why these tumors are so refractory to treatment, and suggests new therapeutic avenues
Combination of olaparib and carboplatin results in complete durable response for a patient with BRCA2 and “BRCAness” mutations
Early communication between oncologists and ophthalmologist warranted
Case-based course delves into latest treatment approaches
Long-term relationship building and engagement key to gaining community trust